Navigation Links
Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock
Date:5/28/2009

BEDFORD, Mass., May 28 /PRNewswire-FirstCall/ -- Now, no matter when a patient with the OmniPod(R) Insulin Management System calls for toll-free customer support, a Spanish-speaking representative is available to help. Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology with its OmniPod System, has expanded its Spanish-speaking customer service to be available 24 hours a day, seven days a week.

"Managing diabetes is a 24-hour-a-day, seven-day-a-week job for our customers, so our goal is to provide best-in-class customer support for all OmniPod users," explained Denise Tise, Insulet's Director of Customer Care and Product Support. "Expanding our Spanish-speaking customer service is particularly valuable for our Spanish-speaking customers in areas with small Hispanic populations, for whom we may be their only source for assistance in using the OmniPod System to manage their diabetes. It's also important as Hispanic youth have one of the highest incidences of Type 1 diabetes of any U.S. ethnic population."

OmniPod System Spanish-speaking customer support representatives can be accessed by calling (800) 591-3455 and following the prompts. The representatives staffing the line are all experts on the OmniPod System and have a business-level fluency in Spanish.

"The OmniPod System has dramatically simplified insulin pump therapy for people living with diabetes," said Dr. Hector Castro, medical director of Beth Israel Latino Health Institute in Manhattan. "By providing round-the-clock Spanish-speaking customer support, Insulet is demonstrating its commitment to making the best treatment option available to the Hispanic community."

Insulet also has the following materials available in Spanish:

OmniPod User Guide (PDF 5.7 MB) http://www.myomnipod.com/pdf/temp/omnipod_userguide_es_us.pdf

This 185-page guide provides a complete set of instructions on the OmniPod and Personal Diabetes Manager (PDM), and is a customer's primary OmniPod System resource.

OmniPod Quick Start Guide (PDF 1.8 MB)

http://www.myomnipod.com/pdf/omnipod_quickstartguide_es.pdf

With instructions for setting up the PDM, and activating and applying the OmniPod, this simple Guide walks users through the steps to starting insulin delivery.

About the OmniPod Insulin Management System

The OmniPod Insulin Management System is the world's only tubing-free insulin pump. OmniPod offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease. OmniPod has just two components: the small, discreet, watertight Pod, worn almost anywhere on the body to hold and deliver insulin; and the PDM (Personal Diabetes Manager), a hand-held device that communicates wirelessly to program the Pod, calculates suggested doses and has a built-in FreeStyle(R) blood glucose meter.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contact:
    Rachel Kessler
    Lazar Partners
    917-660-0608
    rkessler@lazarpartners.com


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says
2. First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says
3. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
4. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
5. OmniPod(R) Insulin Management System Wins 2009 Edison Best New Product Award
6. Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
7. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
8. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
9. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
10. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
11. Frost & Sullivan Cites Gearworks for Creativity and Customer Service in the Home Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ... and patients about the safety issues related to dental restorations. According to the American ... projected to reach $6.4 billion in 2018 with more than 30 million Americans missing ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: